From emergency myelopoiesis to trained immunity? Reframing post-stroke myeloid reprogramming along the brain-bone marrow axis
- 1School of Clinical Medicine, Shandong Second Medical University, Weifang, China
- 2Qingdao Eighth People's Hospital, Shandong Second Medical University, Qingdao, China
Abstract
Ischemic stroke rapidly mobilizes myeloid cells from anatomically distinct bone-marrow niches, while emerging evidence indicates that severe cerebral injury can also leave a durable imprint on hematopoiesis. These observations have encouraged the use of the term trained immunity in stroke biology, but acute myeloid expansion is not equivalent to innate immune memory. In this Mini review, we distinguish acute myeloid activation, myelopoietic responses consistent with emergency myelopoiesis, and central trained immunity involving hematopoietic stem and progenitor cells (HSPCs). We use an operational four-feature framework—persistence, progenitor involvement, epigenetic or metabolic reprogramming, and functional recall—to grade the strength of current evidence. We consider a sequential transition from emergency myelopoiesis to trained immunity as one testable possibility rather than an established pathway, while allowing for parallel or independent mechanisms. The key unresolved questions are where durable memory is stored, when acute hematopoietic adaptation becomes stabilized, and which outputs are maladaptive versus reparative. Resolving these boundaries is essential before marrow-directed immunomodulation can be translated to patients with ischemic stroke.
Related
- The benefits and pitfalls of trained immunity in listeria monocytogenes-based cancer vaccination: how host innate-cell reprogramming may amplify, distort, or constrain the therapeutic potential of live bacterial vectors
- From marrow memory to adverse ventricular remodeling: trained immunity after myocardial infarction
- Immunometabolic synaptopathy: linking metabolic syndrome to epileptogenesis through trained immunity and parvalbumin interneuron vulnerability
- Trained immunity in cancer immunotherapy and vaccine development: mechanisms, evidence gaps, and translational opportunities
- Human macrophages encode stimulus-specific information of prior exposures through trained immunity
BibTeX
@article{wei2026from,
title = {{From emergency myelopoiesis to trained immunity? Reframing post-stroke myeloid reprogramming along the brain-bone marrow axis}},
author = {TongZhu Wei and YongJiu Wang},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1976078},
url = {https://doi.org/10.3389/fneur.2026.1976078},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - From emergency myelopoiesis to trained immunity? Reframing post-stroke myeloid reprogramming along the brain-bone marrow axis
AU - TongZhu Wei
AU - YongJiu Wang
PY - 2026
DA - 2026/10/12
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1976078
UR - https://doi.org/10.3389/fneur.2026.1976078
AB - Ischemic stroke rapidly mobilizes myeloid cells from anatomically distinct bone-marrow niches, while emerging evidence indicates that severe cerebral injury can also leave a durable imprint on hematopoiesis. These observations have encouraged the use of the term trained immunity in stroke biology, but acute myeloid expansion is not equivalent to innate immune memory. In this Mini review, we distinguish acute myeloid activation, myelopoietic responses consistent with emergency myelopoiesis, and central trained immunity involving hematopoietic stem and progenitor cells (HSPCs). We use an operational four-feature framework—persistence, progenitor involvement, epigenetic or metabolic reprogramming, and functional recall—to grade the strength of current evidence. We consider a sequential transition from emergency myelopoiesis to trained immunity as one testable possibility rather than an established pathway, while allowing for parallel or independent mechanisms. The key unresolved questions are where durable memory is stored, when acute hematopoietic adaptation becomes stabilized, and which outputs are maladaptive versus reparative. Resolving these boundaries is essential before marrow-directed immunomodulation can be translated to patients with ischemic stroke.
SN - 1664-2295
ER -